(272 days)
No
The description focuses on standard RF technology and a user interface for parameter selection, with no mention of AI or ML capabilities.
Yes
The device is intended for the non-invasive "treatment" of mild to moderate facial wrinkles and rhytides, which falls under the definition of a therapeutic purpose.
No
Explanation: The device description and intended use clearly state that the Venus Freeze is a non-invasive device for the "non-invasive treatment of mild to moderate facial wrinkles and rhytides." There is no mention of it being used to diagnose any condition, but rather to treat one.
No
The device description clearly outlines multiple hardware components including a main unit, touch screen, RF power module, controller unit, and two treatment applicators. This is not a software-only device.
Based on the provided information, the Venus Freeze device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "non-invasive treatment of mild to moderate facial wrinkles and rhytides" in "Dermatologic and general surgical procedures." This describes a therapeutic or cosmetic treatment applied directly to the patient's body, not a diagnostic test performed on samples taken from the body.
- Device Description: The device description details a system that delivers radiofrequency energy to the skin using applicators. This is consistent with a treatment device, not a device that analyzes biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (like blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information about a patient's health status.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Venus Freeze does not fit this description.
N/A
Intended Use / Indications for Use
The Venus Freeze is a non-invasive device intended for use in Dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides.
Product codes
GEI
Device Description
The Venus Freeze is a noninvasive, non-ablative device consisting of:
- Main Unit (console)
- Touch Screen user interface
- RF Power module
- Controller unit
- Two treatment applicators:
(1) Octipolar "M applicator - for large treatment areas, composed of 8 RF electrodes
(2) Diamondpolar™ applicator - for small treatment areas, composed of 4 RF electrodes.
The Touch Screen user interface allows the selection of treatment parameters (time and power) by pressing on the treatment buttons and displays the current treatments settings.
The Controller Unit provides the operational and safety function of the system.
Treatment applicators transmit Bi-Polar RF energy in a method that creates an organized Bi-Polar RF energy matrix which produces homogeneous heating in the entire treatment area for maximum safety and efficacy, eliminating the need for pre/post cooling mechanisms.
The RF power module provides RF energy to the selected applicator, producing a 1MHz signal.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
facial
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Dermatologic and general surgical procedures
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The safety and efficacy of radiofrequency devices emitting energy with a frequency of 1000 KHz and power of 37 to 150 W is well established in scientific research and clinical studies. Multiple studies with these and similar systems have shown safety in dermatologic therapy and the devices were cleared by the FDA for therapy of wrinkles and rhytides.
Due to the comprehensive animal and clinical study performed in scientific research and published in the literature, and since the power and frequency of the Freeze are well within the previously cleared values, Venus-Concept believes that animal and clinical studies are not required to determine the safety and efficacy of the device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
VENUSCORCEPT
11/2
510(K) SUMMARY
Venus Freeze System 510(k) Number K | 09 58 b
Applicant's Name: Venus Concept Ltd. 62 HaHermesh Street Karmiel, 21652, Israel Tel: (972)3-644-6656 Fax: (972)3-644-6319
Contact Person: Yoram Levy, Qsite 31 Haavoda St. Binyamina, Israel 30500 Tel (972)4-638-8837; Fax (972)4-638-0510 Yoram@gsitemed.com
Trade Name: Venus Freeze
Preparation Date: February 28, 2010
Classification: Name: Electrosurgical, cutting & coagulation device & accessories Product Code: GEI Regulation No: 21 CFR 878.4400 Class: II Panel: General and Plastic Surgery
Device Description:
The Venus Freeze is a noninvasive, non-ablative device consisting of:
- Main Unit (console) -
- Touch Screen user interface -
- -RF Power module
- Controller unit -
- Two treatment applicators:
(1) Octipolar "M applicator - for large treatment areas, composed of 8 RF electrodes
(2) Diamondpolar™ applicator - for small treatment areas, composed of 4 RF electrodes.
2-2
Venus Freeze - 510k submission
1
Venusconcept
The Touch Screen user interface allows the selection of treatment parameters (time and power) by pressing on the treatment buttons and displays the current treatments settings.
The Controller Unit provides the operational and safety function of the system.
Treatment applicators transmit Bi-Polar RF energy in a method that creates an organized Bi-Polar RF energy matrix which produces homogeneous heating in the entire treatment area for maximum safety and efficacy, eliminating the need for pre/post cooling mechanisms.
The RF power module provides RF energy to the selected applicator, producing a 1MHz signal.
Intended Use Statement:
The Venus Freeze is a non-invasive device intended for use in Dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides.
Predicate Devices: Substantial equivalence to the following predicate devices is claimed:
| Device Name | 510k No | Date of Clearance |
|---|---|---|
| EndyMed Imagine TC Skin | ||
| Treatment System | K083461 | Jul 24 2009 |
| Lumenis Aluma | K051214 | Oct 24 2005 |
| Syneron Polaris | K031671 | Dec 01 2003 |
Performance Standards
Venus Freeze complies with ANSI AAMI 60601-2-2 for safety of high frequency surgical equipment,
In addition, the device complies with the European Medical Directive 93/42/EEC concerning medical devices (Annex II) and with the following voluntary standards:
. EN 60601-1 (Medical Electrical Equipment-Part 1: General Requirements for Safety-1. Collateral Standard: Safety Requirements for Medical Electrical Systems).
- IEC 60601-1-2 (Medical Electrical Equipment Part 1-2: Collateral . Standard: Electromagnetic Compatibility - Requirements and Tests)
A detailed description appears in Section 14.
2
VENUSCONCEPT
Summary of Clinical performance data
The safety and efficacy of radiofrequency devices emitting energy with a frequency of 1000 KHz and power of 37 to 150 W is well established in scientific research and clinical studies. Multiple studies with these and similar systems have shown safety in dermatologic therapy and the devices were cleared by the FDA for therapy of wrinkles and rhytides.
Due to the comprehensive animal and clinical study performed in scientific research and published in the literature, and since the power and frequency of the Freeze are well within the previously cleared values, Venus-Concept believes that animal and clinical studies are not required to determine the safety and efficacy of the device.
2-4 Venus Freeze - 510k submission
3
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
NOY 2 9 2010
Venus Concept Ltd. % Qsite Mr. Yoram Levy 31 Haavoda Street Binyamina, Israel 30500
Re: K100586
Trade/Device Name: Venus Freeze Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: October 27, 2010 Received: November 16, 2010
Dear Mr. Levy:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA mav publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
4
Page 2 - Mr. Yoram Levy
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark M Millkenss
Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
VENUSCORCEPT
INDICATIONS FOR USE STATEMENT 100586
510(k) Number (if known):
Device Name:
Venus Freeze
Indications for Use:
The Venus Freeze is a non-invasive device intended for use in Dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-off) Division of General, Restorative and Neurological Devices 510(k) Number
Nilber Doyle for mxm
(Division Sign-Off)
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K100586
1-2 Venus Freeze - 510k Notification